Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Capital Structure Change

Ind-Swift Laboratories Capital Structure Change

Promoter entity Essix Biosciences Limited acquired 70,00,000 fully convertible warrants of Ind-Swift Laboratories via a preferential allotment.

Source

NSE filing, NSE: INDSWFTLAB. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Ind-Swift Laboratories Ltd: key numbers

Share price
₹378.95
Market cap
₹3,295 Cr
Revenue (annual)
₹649.1 Cr
Net profit (annual)
₹43.12 Cr
P/E (TTM)
57.5×Sector 46.1×
Promoter holding
42.93%+0.00% QoQ
FII holding
10.78%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Ind-Swift Laboratories Ltd

All →

Other capital structure change announcements

All →